Acute Coronary Syndrome Clinical Trial
— MindTheHeartOfficial title:
Mind the Heart: Best Practices for Prevention, Early Identification and Treatment of Mood and Anxiety Disorders in Men With Heart Disease
Mood disorders, anxiety disorders, and trauma-related stress (MD\AD\TRS) are common among
men, particularly those suffering from heart disease (HD). MD\AD\TRS are significantly
related to exacerbation of HD symptoms that often lead to death. Unfortunately, men are
significantly less likely than women to seek and receive appropriate treatment for their
mental health issues including MD\AD\TRS. Furthermore, there is little literature about the
use of the stepped care model in the Canadian setting.
The overarching goal of this interventional program is therefore to prevent, early detect and
treat MD\AD\TRS in men living with HD. This Participatory Action Research aims to implement a
stepped-care model for MD\AD\TRS in men in New Brunswick, Ontario, and quebec. The second
phase of the project proposes a quantitative study that will consist of testing the
effectiveness and acceptability (by the men and the involved health professionals) of the
stepped-care model. It will offer to post ACS-males a mental health related component
presently not available in the typical services of the NB health system.
Data will be collected at baseline (0 month) and at four follow-up (each 3-months) sessions
to manage the progress of each participant throughout their 12-month journey in the study.
Typical sociodemographic data will be collected, along with a questionnaire on Masculinity
Norms, Couples Satisfaction (when applicable), and four mental health assessment tools.
Status | Not yet recruiting |
Enrollment | 3000 |
Est. completion date | December 31, 2019 |
Est. primary completion date | December 31, 2018 |
Accepts healthy volunteers | No |
Gender | Male |
Age group | 18 Years to 95 Years |
Eligibility |
Inclusion Criteria: - New Brunswick, Ontario and Quebec sites: 1. men with a diagnosis of ACS (Acute cardiac syndrome) : myocardial infarction such as ST-segment elevation myocardial infarction (STEMI), non-ST-segment elevation myocardial infarction (NSTEMI), or unstable angina, or angioplasty with or without a stent or coronary bypass in the last 3 months. 2. able to speak or write in English or French 3. with an identified treating health professional (cardiologist, family doctor or nurse practitioner). 4. able to attend 8 weekly sessions if qualifies for step 2; 5. available for at least one year of follow-up. - New-Brunswick site only: 1. Surgery patients (surgery in the last three months) will also be included (CABG, Percutaneous valve, Valve, Valve/Graft, Cardioverter (pacemaker), …) 2. Congestive heart failure : patients with NYHA Class III or NYHA Class IV. Exclusion Criteria: - Abuse of any substance in the past 12 months such as alcohol, cannabis, drugs as screened by the Simple Screening Instrument for Substance Abuse; - Self-reported personal history of psychotic disorders or bipolar disorders (i.e. schizophrenia, paranoia, personality disorders - Recently (3 months or less) started on psychotherapy or pharmacological treatment of MD/AD/TRS. |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Universite de Moncton | Movember Foundation, New Brunswick Health Research Foundation |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Change from Baseline GAD-7 at 12 months | The GAD-7 score is calculated by assigning scores of 0, 1, 2, and 3, to the response categories of 'not at all', 'several days', 'more than half the days', and 'nearly every day', respectively, and adding together the scores for the seven questions. | Baseline, 3 months, 6 months, 9 months and 12 months | |
Other | Change from Baseline MDRS-22 at 12 months | Male Depression Risk Scale (MDRS-22) is a 22-item measure that employs a 7-point rating scale (0 = not at all, 7 = almost always). | Baseline, 3 months, 6 months, 9 months and 12 months | |
Primary | Change from Baseline PHQ9 at 12 months | Questionnaire for Depression Scoring: Minimal depression (0-4); Mild depression (5-9); Moderate depression (10-14); Moderately severe depression (15-19); Severe depression (20-27) | Baseline, 3 months, 6 months, 9 months and 12 months | |
Primary | Change from Baseline DASS-21 at 12 months | set of three self-report scales designed to measure the emotional states of depression, anxiety and stress. Each of the three DASS-21 scales contains 7 items, divided into subscales with similar content. The depression scale assesses dysphoria, hopelessness, devaluation of life, self-deprecation, lack of interest / involvement, anhedonia and inertia. The anxiety scale assesses autonomic arousal, skeletal muscle effects, situational anxiety, and subjective experience of anxious affect. The stress scale is sensitive to levels of chronic nonspecific arousal. It assesses difficulty relaxing, nervous arousal, and being easily upset / agitated, irritable / over-reactive and impatient. Scores for depression, anxiety and stress are calculated by summing the scores for the relevant items. | Baseline, 3 months, 6 months, 9 months and 12 months | |
Primary | Change from Baseline IES-R at 12 months | The IES-R is a 22-item self-report measure that assesses subjective distress caused by traumatic events.Items are rated on a 5-point scale ranging from 0 ("not at all") to 4 ("extremely"). The IES-R yields a total score (ranging from 0 to 88) and subscale scores can also be calculated for the Intrusion, Avoidance, and Hyperarousal subscales. | Baseline, 3 months, 6 months, 9 months and 12 months | |
Secondary | Change from Baseline CSI-32 at 12 months | A 32-item scale designed to measure one's satisfaction in a relationship. The scale has a variety of items with different response scales and formats. The authors have also specified that the scale safely be shrunk to either a 16-item format or even a 4-item format depending on a researcher's needs. | Baseline, 3 months, 6 months, 9 months and 12 months | |
Secondary | Change from Baseline CMNI-22 at 12 months | Conformity to Masculine Norms Inventory-Abbreviated version. Self-descriptive statements that measure individual behaviors, attitudes, and conformity to an assortment of dominant masculine norms in the United States. | Baseline, 3 months, 6 months, 9 months and 12 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05846893 -
Drug-Coated Balloon vs. Drug-Eluting Stent for Clinical Outcomes in Patients With Large Coronary Artery Disease
|
N/A | |
Recruiting |
NCT06013813 -
Conventional vs. Distal Radial Access Outcomes in STEMI Patients Treated by PCI
|
N/A | |
Recruiting |
NCT05412927 -
AngelMed Guardian® System PMA Post Approval Study
|
||
Completed |
NCT02750579 -
Early or Delayed Revascularization for Intermediate and High-risk Non ST-elevation Acute Coronary Syndromes?
|
N/A | |
Completed |
NCT04102410 -
Assessing Force-velocity Profile: an Innovative Approach to Optimize Cardiac Rehabilitation in Coronary Patients
|
N/A | |
Enrolling by invitation |
NCT03342131 -
Serum Concentration of Wnt2 and Wnt4 in Patients With Acute Coronary Syndrome
|
N/A | |
Recruiting |
NCT01218776 -
International Survey of Acute Coronary Syndromes in Transitional Countries
|
||
Enrolling by invitation |
NCT04676100 -
International CR Registry
|
||
Completed |
NCT03590535 -
5th Generation cTnT in ED ACS
|
||
Recruiting |
NCT05437900 -
INSIGHTFUL-FFR Clinical Trial
|
Phase 4 | |
Completed |
NCT05551429 -
Factors Related to Participation in Cardiac Rehabilitation in Patients With Acute Coronary Syndrome
|
||
Terminated |
NCT04316481 -
IDE-ALERTS Continued Access Study
|
N/A | |
Active, not recruiting |
NCT04475380 -
Complex All-comers and Patients With Diabetes or Prediabetes, Treated With Xience Sierra Everolimus-eluting Stents
|
||
Not yet recruiting |
NCT04852146 -
Electronic Feedback for Data Restitution and Valorization to the Emergency Teams in Aquitaine.
|
||
Active, not recruiting |
NCT02892903 -
In the Management of Coronary Artery Disease, Does Routine Pressure Wire Assessment at the Time of Coronary Angiography Affect Management Strategy, Hospital Costs and Outcomes?
|
N/A | |
Completed |
NCT02944123 -
Half Dose of Prasugrel and Ticagrelor in Acute Coronary Syndrome (HOPE-TAILOR)
|
Phase 3 | |
Completed |
NCT04077229 -
Piloting Text Messages to Promote Positive Affect and Physical Activity
|
N/A | |
Not yet recruiting |
NCT02871622 -
BMX Alpha Registry: a Post-market Registry of the BioMatrix Alpha TM
|
N/A | |
Active, not recruiting |
NCT02922140 -
The Impact of Pharmaceutical Care Practice on Patients in Cardiac Rehabilitation Unit
|
N/A | |
Completed |
NCT02673437 -
Rivaroxaban ACS Specialist Cohort Event Monitoring Study
|